Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22797645 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Condition: Chronic Hepatitis C
Interventions: Drug: Silymarin;   Other: Placebo

Indicates status has not been verified in more than two years